Physician profile
Pushpak Taunk
NPI 1275794372
$19,759.85
in general payments reported to CMS, 2019-2025
9 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $158 · 2021: $210 · 2022: $632 · 2023: $17K · 2024: $1,176 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $1,631 · Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,750.00 |
| Travel and Lodging | $1,630.95 |
| Food and Beverage | $1,612.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,687.08 | 2019-2025 | Axios, Exalt Model D, Wallflex Duodenal |
| Lumendi LLC | $292.33 | 2019 | |
| Cook Medical LLC | $232.03 | 2020-2021 | |
| Medtronic, INC. | $208.81 | 2023-2024 | Prodigi, Nexpowder |
| Alk-Abello, INC | $144.73 | 2023 | Ragwitek, Odactra, Grastek |
| Endogastric Solutions, INC | $70.22 | 2023 | Esophyx |
| Conmed Corporation | $63.81 | 2025 | Conmed Biliary, Conmed Dilation |
| Shire North American Group INC | $40.58 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pushpak Taunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.